miR-16 directly binds to the 3′UTR of GLS2 mRNA to inhibit bladder cancer growth, whereas lncUCA1 was found to interfere with miR-16’s tumor suppressor role in bladder cancer cells. Here, GLS2 is linked to urinary bladder cancer.